Hannover Rueck (FRA:HNR1) has been given a €108.00 ($133.33) target price by investment analysts at JPMorgan Chase & Co. in a note issued to investors on Wednesday. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s target price would suggest a potential downside of 1.37% from the stock’s current price.
A number of other analysts have also issued reports on HNR1. Jefferies Group set a €109.00 ($134.57) price target on shares of Hannover Rueck and gave the stock a “neutral” rating in a research note on Tuesday, January 30th. Barclays set a €105.40 ($130.12) price objective on Hannover Rueck and gave the stock a “sell” rating in a research report on Thursday, February 1st. Royal Bank of Canada set a €117.00 ($144.44) price objective on Hannover Rueck and gave the stock a “neutral” rating in a research report on Wednesday. DZ Bank reissued a “buy” rating on shares of Hannover Rueck in a research report on Wednesday, December 27th. Finally, Deutsche Bank set a €110.00 ($135.80) price objective on Hannover Rueck and gave the stock a “neutral” rating in a research report on Friday, February 2nd. Three investment analysts have rated the stock with a sell rating, seventeen have assigned a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of €109.24 ($134.86).
Shares of Hannover Rueck (HNR1) opened at €109.50 ($135.19) on Wednesday. The stock has a market cap of $13,140.00 and a PE ratio of 14.20. Hannover Rueck has a one year low of €94.75 ($116.98) and a one year high of €116.37 ($143.67).
About Hannover Rueck
Hannover R??ck SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, and facultative, as well as credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.
Receive News & Ratings for Hannover Rueck Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Rueck and related companies with MarketBeat.com's FREE daily email newsletter.